Brazil health regulation "bundling" triggers Anvisa rethink
This article was originally published in Clinica
Brazil's ongoing devolution of healthcare regulation is seeing state and municipal healthcare authorities tending to merge the five tiers of health-related surveillance. So said Maria Cecília Martins Brito, director of national agency Anvisa, last week, at the end of a two-day conference of healthcare leaders, held to "discuss the necessity and the options" for better linking the healthcare elements at a local level. The five components of Brazil's health-related regulation are: healthcare, epidemiology, environmental, nutritional and health & safety at work.
You may also be interested in...
EU Approvals: Takeda advances its targeted ALK-positive NSCLC tyrosine kinase inhibitor into early lines of therapy, while Bayer and Finland’s Orion gain clearance for their androgen receptor inhibitor for prostate cancer.
The pharma giants are joining forces to help the UK reach its ambitious target of testing 100,000 people a day for coronavirus by the end of April.
Angelini is looking to take its recently-acquired ThermaCare brand to the next level by establishing a direct base in Germany to market the product and through a new distribution deal with Norway's Navamedic.